Literature DB >> 18241893

Angiogenic sprouting from the aortic vascular wall is impaired in the BB rat model of autoimmune diabetes.

Geanina Onuta1, Peter E Westerweel, André Zandvoort, Manon van Riezen, Jan Rozing, Jan-Luuk Hillebrands, Marianne C Verhaar.   

Abstract

BACKGROUND: Diabetes is associated with impaired neovascularization leading to reduced revascularization of ischemic tissue and impaired wound healing. Endothelial progenitor cells in diabetes were previously shown to be numerically reduced and functionally impaired. We hypothesize that diabetes also has a long-term effect on angiogenic cells residing in the vessel wall. To test this hypothesis, angiogenic sprout formation from ex vitro cultured aortic rings isolated from diabetic and non-diabetic BioBreeding (BB) rats was assessed.
METHODS: Diabetes prone BB (BBDP) rats spontaneously develop autoimmune diabetes were suboptimally treated with insulin by subcutaneous implantation of slow-release insulin-pellets. Neonatally thymectomized BBDP rats, pre-diabetic BBDP rats and diabetes resistant BBDR rats served as non-diabetic controls. After follow-up thoracic aortas were harvested and cultured in vitro in Matrigel to induce sprout formation. Sprout length was quantified after 4, 7, 10 and 14 days of culture. The total number of sprout-derived cells was measured and in vitro proliferative capacity of sprout cells was quantified. Finally, expression of Flk-1, CD31 and smooth muscle alpha-actin on sprout cells was determined.
RESULTS: Mean blood glucose levels in diabetics were significantly elevated compared with non-diabetics. Both long-term and short-term diabetes significantly reduced sprout formation (p<0.05 vs. non-diabetics). Reduced sprout length in diabetics was reflected by significantly reduced numbers of sprout cells that could be isolated (p<0.05 vs. non-diabetics). Isolated sprout cells from diabetics revealed significantly reduced proliferative capacity after in vitro culture (p<0.05 vs. non-diabetics). Immunofluorescent staining indicated an endothelial phenotype of both freshly isolated and in vitro cultured sprout cells as indicated by CD31 and Flk-1 expression and absence of smooth muscle alpha-actin expression.
CONCLUSIONS: Diabetes in BB rats impairs angiogenic sprouting from cells residing in the vascular wall, independent of effects on circulating cells or circulating angiogenic/anti-angiogenic factors. The angiogenic impairment of diabetic sprout cells is, to some extent, imprinted upon the cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18241893     DOI: 10.1016/j.mvr.2007.11.006

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  6 in total

1.  Hyperglycemia limits experimental aortic aneurysm progression.

Authors:  Noriyuki Miyama; Monica M Dua; Janice J Yeung; Geoffrey M Schultz; Tomoko Asagami; Eiketsu Sho; Mien Sho; Ronald L Dalman
Journal:  J Vasc Surg       Date:  2010-08-03       Impact factor: 4.268

2.  Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

Authors:  Monica M Dua; Noriyuki Miyama; Junya Azuma; Geoffrey M Schultz; Mien Sho; John Morser; Ronald L Dalman
Journal:  Surgery       Date:  2010-06-19       Impact factor: 3.982

3.  Presence of lymphatics in a rat tendon lesion model.

Authors:  Herbert Tempfer; Alexandra Kaser-Eichberger; Stefanie Korntner; Christine Lehner; Nadja Kunkel; Andreas Traweger; Andrea Trost; Clemens Strohmaier; Barbara Bogner; Christian Runge; Daniela Bruckner; Karolina Krefft; Ludwig M Heindl; Herbert A Reitsamer; Falk Schrödl
Journal:  Histochem Cell Biol       Date:  2014-11-05       Impact factor: 4.304

4.  Toxicity features of high glucose on endothelial cell cycle and protection by Dan Gua-Fang in ECV-304 in high glucose medium.

Authors:  Xian-Pei Heng; Ke-Ji Chen; Zhen-Feng Hong; Wei-Dong He; Ke-Dan Chu; Jiu-Mao Lin; Hai-Xia Zheng; Liu-Qing Yang; Su-Ping Huang; Yuan-Long Lan; Ling Chen; Fang Guo
Journal:  Chin J Integr Med       Date:  2012-02-09       Impact factor: 1.978

5.  Long-term type 1 diabetes enhances in-stent restenosis after aortic stenting in diabetes-prone BB rats.

Authors:  Geanina Onuta; Hendrik C Groenewegen; Flip A Klatter; Mark Walther Boer; Maaike Goris; Harry van Goor; Anton J M Roks; Jan Rozing; Bart J G L de Smet; Jan-Luuk Hillebrands
Journal:  J Biomed Biotechnol       Date:  2011-02-09

Review 6.  Animal models of diabetic macrovascular complications: key players in the development of new therapeutic approaches.

Authors:  Suvi E Heinonen; Guillem Genové; Eva Bengtsson; Thomas Hübschle; Lina Åkesson; Katrin Hiss; Agnes Benardeau; Seppo Ylä-Herttuala; Ann-Cathrine Jönsson-Rylander; Maria F Gomez
Journal:  J Diabetes Res       Date:  2015-02-15       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.